Neonatal jaundice pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 11: Line 11:


Severe neonatal jaundice may indicate the presence of other conditions contributing to the elevated bilirubin levels, of which there are a large variety of possibilities (see below).  These should be detected or excluded as part of the [[differential diagnosis]] to prevent the development of complications.  They can be grouped into the following categories:
Severe neonatal jaundice may indicate the presence of other conditions contributing to the elevated bilirubin levels, of which there are a large variety of possibilities (see below).  These should be detected or excluded as part of the [[differential diagnosis]] to prevent the development of complications.  They can be grouped into the following categories:
{{familytree/start}}
{{familytree | | | | | | | | | | | | | A01 | | | | |A01=Neonatal jaundice}}
{{familytree | | | | | | | | |,|-|-|-|-|^|-|-|-|-|.|}}
{{familytree | | | | | | | | B01 | | | | | | | | B02|B01=[[Unconjugated bilirubin]]|B02=[[Conjugated bilirubin]]}}
{{familytree | | | | | |,|-|-|^|-|-|.| | | |,|-|-|^|-|-|.| |}}
{{familytree | | | | | C01 | | | | C02 | | C03 | | | | C04 | |C01=[[pathology|Pathologic]] |C02=[[Physiologic]] |C03=[[Hepatic]]|C04=Post-hepatic}}
{{familytree | | |,|-|-|^|-|-|.| | | | | | | | | | | |}}
{{familytree | | C01 | | | | C02 | | | | | | | | | | | |C01=[[hemolysis|Hemolytic]]|C02=Non-hemolytic}}
{{familytree | | |)|-|-|-|-|-|.| | | | | | | | | | | |}}
{{familytree | | C01 | | | | C02 | | | | | | | | | | | |C01=Intrinsic causes|C02=Extrinsic causes}}
{{familytree/end}}


==References==
==References==

Revision as of 20:15, 2 January 2018

Neonatal jaundice Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neonatal jaundice from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neonatal jaundice pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neonatal jaundice pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neonatal jaundice pathophysiology

on Neonatal jaundice pathophysiology

Neonatal jaundice pathophysiology in the news

Blogs on Neonatal jaundice pathophysiology

Directions to Hospitals Treating Neonatal jaundice

Risk calculators and risk factors for Neonatal jaundice pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Pathophysiology

In neonates, benign jaundice tends to develop because of two factors - the breakdown of fetal hemoglobin as it is replaced withadult hemoglobin and the relatively immature hepatic metabolic pathways which are unable to conjugate and so excrete bilirubin as fast as an adult. This causes an accumulation of bilirubin in the body (hyperbilirubinemia), leading to the symptoms of jaundice.

Severe neonatal jaundice may indicate the presence of other conditions contributing to the elevated bilirubin levels, of which there are a large variety of possibilities (see below). These should be detected or excluded as part of the differential diagnosis to prevent the development of complications. They can be grouped into the following categories:

References

Template:WH Template:WS